Product Information
KLOR-CON 10 MEQ TABLET is a brand (anda) product labeled by Upsher-Smith Laboratories LLC, priced at $0.1209 per EA under NDC 00245083611. Its NADAC has been published 35 times since Feb 4, 2026.
FDA first approved this application on Oct 28, 2024. Its Orange Book therapeutic-equivalence code is AB2 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
750 mg/1
Manufacturer
Upsher-Smith Laboratories LLCNDC
00245083611
Classification
Brand (ANDA)
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
POTASSIUM CHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA218979FDA Approved
10/28/2024
TE Code
AB2
On Market Since
8/15/2025
Pharmacological Classes
Price Statistics
The NADAC for KLOR-CON 10 MEQ TABLET has been published 35 times since Feb 4, 2026, and over the history we have for it it has risen 10.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1209 per EA |
|---|---|
| All-time high | $0.1235 (Sep 16, 2026) |
| All-time low | $0.1093 (Feb 4, 2026) |
| 52-week high | $0.1235 |
| 52-week low | $0.1093 |
| Median price | $0.1093 |
| Average price | $0.1136 |
| Largest weekly change | +13.0% (Jul 22, 2026) |
| Weeks tracked | 35 |
| Tracking since | Feb 4, 2026 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 32% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Upsher-Smith Laboratories LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
potassium chloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Osmotic Laxative class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of KLOR-CON 10 MEQ TABLET?
The current National Average Drug Acquisition Cost (NADAC) for KLOR-CON 10 MEQ TABLET, manufactured by Upsher-Smith Laboratories LLC, is $0.1209 per EA (NDC 00245083611), effective Sep 30, 2026.
How has the price of KLOR-CON 10 MEQ TABLET changed over time?
Over the history we have for it, the NADAC for KLOR-CON 10 MEQ TABLET has risen 10.7%. It has been tracked across 35 weekly CMS publications since Feb 4, 2026.
What are the highest and lowest recorded NADAC prices for KLOR-CON 10 MEQ TABLET?
Since Feb 4, 2026, the NADAC for KLOR-CON 10 MEQ TABLET has ranged from a low of $0.1093 (Feb 4, 2026) to a high of $0.1235 (Sep 16, 2026), with a median of $0.1093 per EA.
Are there cheaper alternatives to KLOR-CON 10 MEQ TABLET?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, POTASSIUM CL ER 10 MEQ TABLET, is $0.0828 per EA — about 32% below KLOR-CON 10 MEQ TABLET.
Who manufactures KLOR-CON 10 MEQ TABLET?
KLOR-CON 10 MEQ TABLET (NDC 00245083611) is labeled by Upsher-Smith Laboratories LLC, and CMS classifies it as a brand (anda) product.